Drawing for MERCY HALO

USPTO serial 98583258

MERCY HALO

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
DUBRAY, KATHERINE M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with MERCY HALO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael S. Palmisciano

Michael S. Palmisciano Sullivan & Worcester LLP1251 Avenue of the AmericasNew York, NY 10020United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic kits for medical use, comprised of medical diagnostic reagents and assays for testing blood and other body fluids for use in disease detection, namely, cancer; Diagnostic test strips for medical and laboratory analysis of bloodACTIVE—
010Medical diagnostic, testing and monitoring equipment, namely, blood testing apparatus for taking blood samples and blood analysis for the early detection and location of cancer; Medical devices for obtaining blood samplesACTIVE—
042Medical and scientific research services in the fields of blood analysis health care and health care monitoringACTIVE—
044Providing blood testing and medical diagnostic services, medical diagnostic testing, and medical information in the field of cancer; Providing medical information to medical professionals in the form of reports in the field of cancer; Medical diagnostic testing, namely, consumer-authorized clinical laboratory testing services that report results directly to the patient, consisting of a wellness panel of blood tests; Providing a website featuring educational information in the field of cancer detection and testing; Providing information in the field of cancer detection and testing via social networking and social media websitesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 31, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 31, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 29, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 28, 2026EX3GSOU EXTENSION 3 GRANTED—
Sep 28, 2026EXT3SOU EXTENSION 3 FILED—
Sep 28, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 27, 2026EX2GSOU EXTENSION 2 GRANTED—
Mar 27, 2026EXT2SOU EXTENSION 2 FILED—
Mar 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2025EX1GSOU EXTENSION 1 GRANTED—
Sep 29, 2025EXT1SOU EXTENSION 1 FILED—
Sep 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 30, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 30, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 30, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 30, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2025DOCKASSIGNED TO EXAMINER—
Dec 16, 2024DOCKASSIGNED TO EXAMINER—
Aug 14, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance